- Home
- GPUS vs GTBP Comparison
GPUS vs GTBP Comparison
Compare GPUS & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPUS
- GTBP
- Stock Information
- Founded
- GPUS 1969
- GTBP 1965
- Country
- GPUS United States
- GTBP United States
- Employees
- GPUS N/A
- GTBP N/A
- Industry
- GPUS
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- GPUS
- GTBP Health Care
- Exchange
- GPUS NYSE
- GTBP Nasdaq
- Market Cap
- GPUS 4.8M
- GTBP 5.5M
- IPO Year
- GPUS 1996
- GTBP N/A
- Fundamental
- Price
- GPUS $1.34
- GTBP $2.13
- Analyst Decision
- GPUS
- GTBP Strong Buy
- Analyst Count
- GPUS 0
- GTBP 1
- Target Price
- GPUS N/A
- GTBP $11.00
- AVG Volume (30 Days)
- GPUS 8.9M
- GTBP 119.8K
- Earning Date
- GPUS 08-15-2025
- GTBP 08-13-2025
- Dividend Yield
- GPUS N/A
- GTBP N/A
- EPS Growth
- GPUS N/A
- GTBP N/A
- EPS
- GPUS N/A
- GTBP N/A
- Revenue
- GPUS $93,318,000.00
- GTBP N/A
- Revenue This Year
- GPUS N/A
- GTBP N/A
- Revenue Next Year
- GPUS N/A
- GTBP N/A
- P/E Ratio
- GPUS N/A
- GTBP N/A
- Revenue Growth
- GPUS N/A
- GTBP N/A
- 52 Week Low
- GPUS $1.23
- GTBP $1.72
- 52 Week High
- GPUS $11.73
- GTBP $4.10
- Technical
- Relative Strength Index (RSI)
- GPUS N/A
- GTBP 34.57
- Support Level
- GPUS N/A
- GTBP $1.91
- Resistance Level
- GPUS N/A
- GTBP $3.73
- Average True Range (ATR)
- GPUS 0.00
- GTBP 0.33
- MACD
- GPUS 0.00
- GTBP -0.17
- Stochastic Oscillator
- GPUS 0.00
- GTBP 11.34
About GPUS HYPERSCALE DATA INC
Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has six reportable segments: Energy and Infrastructure; Technology and Finance; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Global Real Estate Equities, Inc.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.